학술논문
A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus BasalBolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c $9–15%: DUAL HIGH Trial
Document Type
Article
Author
Source
In: Diabetes Care . (Diabetes Care, September 2023, 46(9):1640-1645)
Subject
Language
English
ISSN
19355548
01495992
01495992